Atea Pharmaceuticals, Inc. (AVIR) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 192.18M | 32.81M | 60.39M |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | -100% | -100% | -100% | -100% | 295.16% | - | - |
| Cost of Goods Sold | 104K | 0 | 0 | 2.42M | 3.44M | 104K | 19.92M | 104K | 104K | 104K | 18.06M | 16.14M | 28.95M | 14.72M | 0 | 0 | 29.63M | 57.81M | 43.02M | 39.8M |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 30.08% | 131.11% | 65.91% |
| Gross Profit | -104K | 0 | 0 | -2.42M | -3.44M | -104K | -19.92M | -104K | -104K | -104K | -18.06M | -16.14M | -28.95M | -14.72M | 0 | 0 | -29.63M | 134.37M | -10.21M | 20.59M |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 69.92% | -31.11% | 34.09% |
| Gross Profit Growth % | 96.98% | 100% | 100% | -2225.96% | -3207.69% | 0% | -10.32% | 99.36% | 99.64% | 99.29% | - | - | 2.29% | -110.95% | 100% | -100% | -175.18% | 286.26% | 24.95% | 365.48% |
| Operating Expenses | 47.9M | 54.93M | 45.57M | 38.93M | 35.6M | 38.92M | 17.28M | 46.81M | 69.7M | 46.47M | 22.73M | 19.1M | 12.62M | 25.18M | 16.28M | 32.3M | 12.54M | 13.19M | 11.94M | 11.9M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.86% | 36.39% | 19.71% |
| Selling, General & Admin | 6.87M | 7.12M | 7.22M | 9.07M | 9.46M | 13.25M | 11.04M | 12.12M | 12.13M | 11.42M | 12.6M | 13.17M | 12.62M | 12.36M | 11.38M | 12.44M | 12.54M | 13.19M | 11.94M | 11.9M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.86% | 36.39% | 19.71% |
| Research & Development | 41.13M | 47.82M | 38.35M | 32.27M | 29.58M | 25.67M | 26.16M | 34.7M | 57.58M | 35.05M | 31.93M | 29.94M | 29.95M | 28.64M | 4.91M | 19.86M | 30.48M | 57.81M | 43.02M | 39.8M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 30.08% | 131.11% | 65.91% |
| Other Operating Expenses | -104K | 0 | 0 | -1000K | -1000K | 0 | -1000K | 0 | 0 | 0 | -1000K | -1000K | -1000K | -1000K | 0 | 0 | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -48.01M | -54.93M | -45.57M | -41.34M | -39.04M | -39.03M | -37.2M | -46.92M | -69.81M | -46.57M | -40.78M | -35.23M | -41.57M | -39.9M | -16.28M | -32.3M | -42.17M | 121.18M | -22.15M | 8.69M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 63.06% | -67.5% | 14.38% |
| Operating Income Growth % | -22.97% | -40.76% | -22.49% | 11.87% | 44.07% | 16.2% | 8.79% | -33.15% | -67.93% | -16.73% | -150.51% | -9.1% | 1.44% | -132.93% | 26.49% | -471.76% | -237.58% | 486.92% | -25.63% | 186.84% |
| EBITDA | -47.9M | -54.83M | -45.46M | -41.24M | -38.94M | -38.92M | -37.1M | -46.81M | -69.7M | -46.47M | -40.68M | -35.13M | -41.47M | -39.8M | -16.18M | -32.25M | -42.17M | 121.19M | -22.14M | 8.7M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 63.06% | -67.48% | 14.4% |
| EBITDA Growth % | -23.03% | -40.87% | -22.55% | 11.9% | 44.14% | 16.24% | 8.81% | -33.25% | -68.1% | -16.77% | -151.51% | -8.93% | 1.67% | -132.84% | 26.94% | -470.93% | -237.53% | 486.78% | -25.62% | 186.96% |
| D&A (Non-Cash Add-back) | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 106K | 43K | 7K | 7K | 7K | 8K |
| EBIT | -48.01M | -54.93M | -41.85M | -41.42M | -39.04M | -33.32M | -30.97M | -46.92M | -69.81M | -38.81M | -30.66M | -29.31M | -41.57M | -27.08M | -16.28M | -32.3M | -42.17M | 121.18M | -22.15M | 8.69M |
| Net Interest Income | 2.62M | 3.3M | 0 | 4.39M | 4.97M | 5.71M | 6.28M | 6.64M | 6.87M | 7.76M | 7.86M | 7.3M | 6.3M | 5.59M | 4.38M | 1.08M | 98K | 51K | 53K | 52K |
| Interest Income | 2.62M | 3.3M | 0 | 4.39M | 4.97M | 5.71M | 6.28M | 6.64M | 6.87M | 7.76M | 7.86M | 7.3M | 6.3M | 5.59M | 4.38M | 1.08M | 98K | 51K | 53K | 52K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.62M | 3.3M | 3.71M | 4.39M | 4.97M | 5.71M | 6.28M | 6.64M | 6.87M | 7.76M | 7.86M | 7.3M | 6.3M | 5.59M | 4.38M | 1.08M | 98K | 51K | 53K | 52K |
| Pretax Income | -45.39M | -51.63M | -41.85M | -36.95M | -34.07M | -33.32M | -30.93M | -40.28M | -62.94M | -38.81M | -32.92M | -27.93M | -35.27M | -34.31M | -11.9M | -31.21M | -42.08M | 121.23M | -22.09M | 8.74M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 63.08% | -67.34% | 14.47% |
| Income Tax | 50K | -6.77M | 196K | 207K | 203K | 225K | 226K | 243K | 231K | 349K | 221K | 251K | 197K | 123K | -3.83M | 120K | 0 | 4.1M | 6.1M | 7.2M |
| Effective Tax Rate % | -0.11% | 13.11% | -0.47% | -0.56% | -0.6% | -0.68% | -0.73% | -0.6% | -0.37% | -0.9% | -0.67% | -0.9% | -0.56% | -0.36% | 32.21% | -0.38% | 0% | 3.38% | -27.61% | 82.39% |
| Net Income | -45.44M | -44.87M | -42.05M | -37.16M | -34.27M | -33.54M | -31.15M | -40.52M | -63.17M | -39.16M | -33.14M | -28.18M | -35.47M | -34.43M | -8.07M | -31.34M | -42.08M | 117.13M | -28.19M | 1.54M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 60.95% | -85.93% | 2.55% |
| Net Income Growth % | -32.59% | -33.76% | -34.98% | 8.29% | 45.75% | 14.35% | 6.01% | -43.78% | -78.11% | -13.75% | -310.89% | 10.06% | 15.71% | -129.39% | 71.39% | -2136.06% | -237% | 467.06% | -59.99% | 115.4% |
| Net Income (Continuing) | -45.44M | -44.87M | -42.05M | -37.16M | -34.27M | -33.54M | -31.15M | -40.52M | -63.17M | -39.16M | -33.14M | -28.18M | -35.47M | -34.43M | -8.07M | -31.34M | -42.08M | 117.13M | -28.19M | 1.54M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.57 | -0.57 | -0.53 | -0.44 | -0.40 | -0.40 | -0.37 | -0.48 | -0.75 | -0.47 | -0.40 | -0.34 | -0.43 | -0.41 | -0.10 | -0.38 | -0.50 | 1.34 | -0.34 | 0.02 |
| EPS Growth % | -42.5% | -42.5% | -43.24% | 8.33% | 46.67% | 14.89% | 7.5% | -41.18% | -74.42% | -14.63% | -312.8% | 10.53% | 14% | -130.6% | 71.5% | -2000% | -247.06% | 482.61% | -54.55% | 109.52% |
| EPS (Basic) | -0.57 | -0.57 | -0.53 | -0.44 | -0.40 | -0.40 | -0.37 | -0.48 | -0.75 | -0.47 | -0.40 | -0.34 | -0.43 | -0.41 | -0.10 | -0.38 | -0.50 | 1.41 | -0.34 | 0.02 |
| Diluted Shares Outstanding | 79.2M | 78.13M | 79.05M | 83.75M | 85.16M | 84.46M | 84.42M | 84.25M | 83.92M | 83.44M | 83.4M | 83.4M | 83.33M | 83.29M | 83.26M | 83.26M | 83.18M | 87.09M | 82.82M | 88.09M |
| Basic Shares Outstanding | 79.2M | 78.13M | 79.05M | 83.75M | 85.16M | 84.46M | 84.42M | 84.25M | 83.92M | 83.44M | 83.4M | 83.4M | 83.33M | 83.29M | 83.26M | 83.26M | 83.18M | 83.1M | 82.82M | 82.74M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |